Marjut Niinivirta
- E-post:
- marjut.niinivirta@igp.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Publikationer
Senaste publikationer
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Ingår i BMC Cancer, 2020
- DOI för Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
- Ladda ner fulltext (pdf) av Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Ingår i Journal of Cancer, s. 3224-3231, 2019
- DOI för Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
- Ladda ner fulltext (pdf) av Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
Intratumoral Predictive Markers in Metastatic Renal Cancer Patients
2018
Ingår i BMC Cancer, 2017
- DOI för A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
- Ladda ner fulltext (pdf) av A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Ingår i Journal of Cancer, s. 3975-3983, 2017
- DOI för Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
- Ladda ner fulltext (pdf) av Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Alla publikationer
Artiklar i tidskrift
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Ingår i BMC Cancer, 2020
- DOI för Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
- Ladda ner fulltext (pdf) av Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Ingår i Journal of Cancer, s. 3224-3231, 2019
- DOI för Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
- Ladda ner fulltext (pdf) av Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
Ingår i BMC Cancer, 2017
- DOI för A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
- Ladda ner fulltext (pdf) av A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Ingår i Journal of Cancer, s. 3975-3983, 2017
- DOI för Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
- Ladda ner fulltext (pdf) av Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Ingår i Journal of Cancer Research and Clinical Oncology, s. 961-970, 2017
- DOI för Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
- Ladda ner fulltext (pdf) av Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib